Physician profile
Mayur Vora
NPI 1588313381
$2,377.07
in general payments reported to CMS, 2019-2025
18 companies · $1,938 in 2025
The $1,938 reported for 2025 was more than what 93% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $92.11 · 2023: $215 · 2024: $132 · 2025: $1,938.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,507 · Travel and Lodging: $778.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,507.22 |
| Travel and Lodging | $777.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $1,385.36 | 2024-2025 | Barostim Neo System |
| Abbott Laboratories | $361.42 | 2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Bard Peripheral Vascular, INC. | $135.11 | 2023 | Crosser Iq |
| Cardiovascular Systems INC. | $92.11 | 2022 | |
| Baxter Healthcare | $85.93 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Scpharmaceuticals INC. | $40.27 | 2024 | |
| Boston Scientific Corporation | $35.44 | 2025 | Watchman Flx |
| Merck Sharp & Dohme LLC | $33.85 | 2023 | Verquvo |
| Abiomed | $33.44 | 2025 | |
| Kestra Medical Technology Services, INC. | $25.43 | 2025 | Assure Wcd |
| Alnylam Pharmaceuticals INC. | $24.94 | 2025 | Amvuttra |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.32 | 2024 | Lifevest |
| Medtronic, INC. | $23.02 | 2024 | Mycarelink |
| Novartis Pharmaceuticals Corporation | $16.20 | 2024 | |
| Pfizer INC. | $15.71 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $15.38 | 2023 | Repatha |
| Astrazeneca Pharmaceuticals Lp | $14.60 | 2023 | Farxiga |
| Novo Nordisk INC | $14.54 | 2025 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mayur Vora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.